Serono, Inc. Names Paul Lammers Chief Medical Officer
Serono, Inc. (Rockland, MA, www.serono.com) has named Paul Lammers, MD, as its US Chief Medical Officer.
Serono, Inc. (Rockland, MA, www.serono.com) has named Paul Lammers, MD, as its US Chief Medical Officer. In his new role, Lammers will be responsible for overseeing clinical development, including product safety and medical information, and for managing the medical affairs and regulatory affairs functions. The company also named James Hoyes to the role of US Chief Commercial Officer.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
